山东大学教师主页徐欣 In vitro Antibacterial Activity of an FDA-Approved H+-ATPase Inhibitor, Bedaquiline, Against Streptococcus mutans in Acidic Milieus 中文主页

In vitro Antibacterial Activity of an FDA-Approved H+-ATPase Inhibitor, Bedaquiline, Against Streptococcus mutans in Acidic Milieus: 发布时间：2021-10-09 | 点击次数：

所属单位：口腔医学院

发表刊物：Frontiers in Microbiology

第一作者：张萌

论文编号：65E0B5DF16354D449E5F638F78562CDC

卷号：12

字数：3000

是否译文：否

发表时间：2021-02

上一条： Genipin and insulin combined treatment improves implant osseointegration in type 2 diabetic rats

下一条： YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+T cell infiltration